Overview of methicillin resistant Staphylococcus aureus mediated bone and joint infections in India

is the most common pathogen causing bone and joint infections (BJI). In India, prevalence of Methicillin resistant (MRSA) is increasing at an alarming rate and emerged as an important contributor towards the difficult to treat BJI. Currently available anti-MRSA agents have their own limitations with...

Full description

Saved in:
Bibliographic Details
Published in:Orthopedic Reviews 2019-06, Vol.11 (2), p.8070-8070
Main Authors: Prabhoo, Ram, Chaddha, Ram, Iyer, Rajagopalan, Mehra, Apurv, Ahdal, Jaishid, Jain, Rishi
Format: Article
Language:English
Subjects:
Antibiotics
Biofilms
Bone and joint infection
Methicillin resistant S.aureus
Newer anti-MRSA agents
Review
Staphylococcus infections
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:is the most common pathogen causing bone and joint infections (BJI). In India, prevalence of Methicillin resistant (MRSA) is increasing at an alarming rate and emerged as an important contributor towards the difficult to treat BJI. Currently available anti-MRSA agents have their own limitations with regards to reduced susceptibility as well as safety and tolerability. Furthermore, biofilms over the prosthesis with invariably multi-drug resistant strains leads to complex treatment processes. This necessitates the need to develop and screen new antibiotics against MRSA that can easily penetrate the deep pockets of infection and take care of the challenges discussed. This review aims to discuss on MRSA infection in bone and joint infection, current antibiotic regimen, its associated limitations, and finally, the need to develop new antibiotic therapy for effective management of patients with BJI.
ISSN:2035-8237
2035-8164
DOI:10.4081/or.2019.8070